BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 4483127)

  • 1. The effect of selected organophosphorus compounds on plasma and red blood cell cholinesterase in the dog.
    Vestweber JG; Kruckenberg SM
    Vet Med Small Anim Clin; 1972 Jul; 67(7):803-6. PubMed ID: 4483127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of serum cholinesterase using a spin-labelled inhibitor].
    Khodakovskaia OA; Iakovlev VA
    Izv Akad Nauk SSSR Biol; 1975; (4):570-9. PubMed ID: 170322
    [No Abstract]   [Full Text] [Related]  

  • 4. [The cholinesterase activity in red blood cells and blood plasma after oral intake of Atgard vet. (dichlorvos) in pigs (author's transl)].
    Bossen F; Karlog O; Rasmussen F
    Nord Vet Med; 1973 Nov; 25(11):584-7. PubMed ID: 4779070
    [No Abstract]   [Full Text] [Related]  

  • 5. Mammalian brain and erythrocyte cholinesterases exhibit equal sensitivity to some organophosphorus inhibitors.
    Rozengart EV; Basova NE
    Dokl Biochem Biophys; 2007; 417():352-6. PubMed ID: 18274459
    [No Abstract]   [Full Text] [Related]  

  • 6. [Substrate-inhibitor analysis of the hemolymph cholinesterase from the Pacific ocean Neptunea eulimata (Mollusca)].
    Rozengart EV
    Zh Evol Biokhim Fiziol; 2001; 37(3):165-9. PubMed ID: 11605434
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinesterase activity in plasma, red blood cells, muscle, and brain of dogs following repeated exposure to Spotton (fenthion).
    Sundlof SF; Clemmons RM; Meyer DJ; Rappaport JJ; Fossler ME; Hubbell J
    Vet Hum Toxicol; 1984 Apr; 26(2):112-7. PubMed ID: 6730296
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between the severity of symptoms in organophosphorus poisoning and cholinesterase activity (RBC and plasma) in humans.
    Bobba R; Venkataraman BV; Pais P; Joseph T
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):249-52. PubMed ID: 8950142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dichlorvos on blood cholinesterase activity in dogs.
    Ward FP; Glicksberg CL
    J Am Vet Med Assoc; 1971 Feb; 158(4):457-61. PubMed ID: 5545548
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of tri-aryl phosphates upon cholinesterase.
    Bondy HF; Hughes JP; Leahy JS; Worden AN
    Toxicology; 1973 Jun; 1(2):143-50. PubMed ID: 4795109
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical elevation of plasma cholinesterase.
    Alexiou NG; Williams JF; Yeung HW; Husting EL
    Am J Prev Med; 1986; 2(4):235-8. PubMed ID: 3502583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of brain cholinesterase by organophosphorus compounds in rats.
    Reiff B; Lambert SM; Natoff IL
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):48-60. PubMed ID: 5093191
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
    Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
    Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticholinesterase effect of potential organophosphorus synergists of pyrethroids].
    Khrunin AV; Eremina OIu
    Gig Sanit; 2000; (3):66-70. PubMed ID: 10900804
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of organo- phosphorus compounds on plasma cholinesterase levels in industrial and non-industrial workers in Port Harcourt.
    Orluwene CG; Ejilemele AA; Ojule AC; Wakwe VC
    Niger Postgrad Med J; 2007 Jun; 14(2):84-9. PubMed ID: 17599101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between the observed variations in the inhibition of serum cholinesterase by E 600 and the activity of the enzyme system from human serum which cleaves E 600].
    Geldmacher-von Mallinck ; Baumgartner W; Pétenyi M; Burgis H; Lindorf HH; Metzner H
    Hoppe Seylers Z Physiol Chem; 1972 Feb; 353(2):217-20. PubMed ID: 5027705
    [No Abstract]   [Full Text] [Related]  

  • 17. Benzamides and cholinesterases.
    Vacca C; Maione S; Tozzi A; Marmo E
    Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):193-201. PubMed ID: 3823608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the capacity of obidoxime chloride to reactivate phosphorylated blood cholinesterases in vivo].
    Hahn HL; Henschler D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):130-1. PubMed ID: 4239168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of cholinesterases of varying origin by ordinary and betaine vinylphosphates].
    Zhukovskiĭ IuG; Kuznetsova LP; Sochilina EE; Dmitrieva EN; Gololobov IuG; Bykovskaia EIu
    Ukr Biokhim Zh (1978); 1996; 68(5):15-20. PubMed ID: 9229847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and anticholinesterase activity of acetylene organophosphorus compounds].
    Balashova EK; Brestkin AP; Zhukovskiĭ IuG; Rozengart VI; Sherstobitov OE
    Dokl Akad Nauk SSSR; 1983; 272(2):503-6. PubMed ID: 6679836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.